Dallas TX 2型糖尿病临床试验
18项针对 2型糖尿病的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- University of Texas Southwestern Medical Center, Dallas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Soltero Cardiovascular Research Center, Dallas
- North Texas Endocrine Center, Dallas
- Southwest Family Medicine Associates, Dallas
- 以及另外 1 项
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Velocity Clinical Research, Dallas
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Velocity Clinical Research, Dallas, Dallas
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Dallas
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
招募中2 期
- M3 Wake Research Dallas - Internal Medicine, Dallas
- Revival Research Institute, LLC, Dallas
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Dallas
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
招募中2 期
- Zenos Clinical Research, Dallas
The RESET System Pivotal Clinical Trial (Protocol Revision K)
招募中
- M3 Wake Research, Dallas
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Velocity Clinical Research - Dallas, Dallas
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
招募中3 期
- North Texas Endocrine Center, Dallas
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
招募中
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
招募中2 期
- University of Texas Southwestern Medical Center, Dallas
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Thyroid Endocrinology & Diabetes PA, Dallas
- Baylor Jack and Jane Hamilton, Dallas
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
招募中3 期
- Research Institute of Dallas, Dallas
Polypill for Prevention of Cardiomyopathy
招募中1/2 期
- UT Southwestern Medical Center, Dallas
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
招募中2 期
- Velocity Clinical Research Dallas, Dallas
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
招募中
- UT Southwestern Medical Center, Dallas
其他城市的 2型糖尿病试验
- San Antonio, TX37 项研究
- Houston, TX31 项研究
- Orlando, FL25 项研究
- Atlanta, GA21 项研究
- San Diego, CA21 项研究
- Boston, MA20 项研究
- Miami, FL20 项研究
- Chicago, IL19 项研究
- Arlington, VA19 项研究
- Los Angeles, CA18 项研究
- Columbus, OH17 项研究
- Las Vegas, NV17 项研究
Dallas的其他研究
- 乳腺癌54 项研究
- 非小细胞肺癌53 项研究
- 转移性癌症44 项研究
- 心力衰竭42 项研究
- 癌症（所有类型）40 项研究
- 前列腺癌39 项研究
- 结直肠癌34 项研究
- 肥胖症33 项研究
- 卵巢癌31 项研究
- 膀胱癌27 项研究
- 肺癌26 项研究
- 子宫内膜癌25 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。